Longboard Pharmaceuticals Statistics
Total Valuation
LBPH has a market cap or net worth of $2.33 billion. The enterprise value is $2.05 billion.
Important Dates
The last earnings date was Thursday, November 7, 2024, after market close.
| Earnings Date | Nov 7, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
LBPH has 39.05 million shares outstanding. The number of shares has increased by 63.09% in one year.
| Current Share Class | 34.44M |
| Shares Outstanding | 39.05M |
| Shares Change (YoY) | +63.09% |
| Shares Change (QoQ) | +0.20% |
| Owned by Insiders (%) | 0.98% |
| Owned by Institutions (%) | 73.25% |
| Float | 26.14M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 8.47 |
| P/TBV Ratio | 8.48 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 15.97, with a Debt / Equity ratio of 0.01.
| Current Ratio | 15.97 |
| Quick Ratio | 15.72 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -46.66% and return on invested capital (ROIC) is -32.98%.
| Return on Equity (ROE) | -46.66% |
| Return on Assets (ROA) | -30.72% |
| Return on Capital (ROIC) | -32.98% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.53M |
| Employee Count | 50 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +1,280.14% in the last 52 weeks. The beta is 1.09, so LBPH's price volatility has been similar to the market average.
| Beta (5Y) | 1.09 |
| 52-Week Price Change | +1,280.14% |
| 50-Day Moving Average | 47.55 |
| 200-Day Moving Average | 30.70 |
| Relative Strength Index (RSI) | 79.46 |
| Average Volume (20 Days) | 845,586 |
Short Selling Information
The latest short interest is 1.92 million, so 4.93% of the outstanding shares have been sold short.
| Short Interest | 1.92M |
| Short Previous Month | 5.17M |
| Short % of Shares Out | 4.93% |
| Short % of Float | 7.36% |
| Short Ratio (days to cover) | 0.58 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -87.45M |
| Pretax Income | -64.74M |
| Net Income | -76.34M |
| EBITDA | -87.45M |
| EBIT | -87.45M |
| Earnings Per Share (EPS) | -$2.23 |
Full Income StatementBalance Sheet
The company has $288.45 million in cash and $3.73 million in debt, giving a net cash position of $284.71 million or $7.29 per share.
| Cash & Cash Equivalents | 288.45M |
| Total Debt | 3.73M |
| Net Cash | 284.71M |
| Net Cash Per Share | $7.29 |
| Equity (Book Value) | 275.19M |
| Book Value Per Share | 7.05 |
| Working Capital | 274.68M |
Full Balance SheetCash Flow
| Operating Cash Flow | -65.93M |
| Capital Expenditures | n/a |
| Free Cash Flow | -65.93M |
| FCF Per Share | -$1.69 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |